公司资料
T2 Biosystems 股价、新闻与催化剂
- 股票代码:
- TTOO
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年10月1日
—
市值
股价为何变动
截至 2026年10月1日，TTOO 股价变化不大，收于 $0.0006。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
T2 Biosystems is a medical diagnostics company focused on rapid pathogen detection and bloodstream infection testing. Its business is centered on delivering fast diagnostic information to clinical settings.
所在地与行业分类
T2 Biosystems is headquartered in the United States and listed on NASDAQ. It sits in medical diagnostics rather than biotechnology therapeutics.
商业模式特征
The company depends on test adoption, hospital utilization, and commercialization execution in a challenging diagnostics market. Investors usually watch sales, reimbursement, and operating discipline.
生物医药行业定位
T2 Biosystems belongs to the diagnostics infrastructure layer of healthcare. It is not a drug developer, but it matters to clinical workflow because rapid testing can change treatment decisions.
未来催化剂
- T2 Biosystems is a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update. There is no active standalone growth story left.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。